<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Treatment of relapse after allogenic stem cell transplantation (allo-SCT) is challenging </plain></SENT>
<SENT sid="1" pm="."><plain>The efficacy of donor leukocyte infusions (DLI) is excellent in <z:hpo ids='HP_0011010'>chronic</z:hpo> phase <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> but limited in other disorders </plain></SENT>
<SENT sid="2" pm="."><plain>We present a patient who relapsed 10 months after reduced intensity conditioning allo-SCT for a myelodysplastic/ myeloproliferative <z:hpo ids='HP_0002664'>neoplasm</z:hpo> with <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> despite receiving escalating doses of DLI for incomplete chimerism </plain></SENT>
<SENT sid="3" pm="."><plain>He finally achieved complete remission with full whole blood and T-cell donor chimerism after DLI preceded by lymphodepletion chemotherapy </plain></SENT>
<SENT sid="4" pm="."><plain>This case demonstrates that chemotherapy prior to DLI is a useful approach for treating relapses of relatively <z:hpo ids='HP_0003677'>slowly progressive</z:hpo> diseases, such as <z:mpath ids='MPATH_512'>myeloproliferative diseases</z:mpath> or <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> </plain></SENT>
</text></document>